LLC-PK1 cells stably expressing the human norepinephrine transporter: A functional model of carrier-mediated norepinephrine release in protracted myocardial ischemia

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 456-463

  Smith, Neil C E ^a   Levi, Roberto ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 5 (N ETHYL N ISOPROPYL)AMILORIDE; ADENOSINE TRIPHOSPHATE; CARRIER PROTEIN; CHLORIDE; DESIPRAMINE; GRAMICIDIN; MAZINDOL; NIGERICIN; NORADRENALIN; OUABAIN; SODIUM;

ANIMAL CELL; ARTICLE; CELL LINE; CELL PH; DNA TRANSFECTION; HEART MUSCLE ISCHEMIA; HYPOXIA; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON SODIUM EXCHANGE; SIGNAL TRANSDUCTION; SODIUM CELL LEVEL;

1-METHYL-4-PHENYLPYRIDINIUM; AMILORIDE; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; DESIPRAMINE; DRUG INTERACTIONS; GRAMICIDIN; HUMANS; LLC-PK1 CELLS; MAZINDOL; MODELS, BIOLOGICAL; MYOCARDIAL ISCHEMIA; NIGERICIN; NOREPINEPHRINE; RECEPTORS, DRUG; SODIUM; SWINE; TIME FACTORS;

EID: 0032722763     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Buck KJ and Amara SG (1994) Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc Natl Acad Sci USA 91:12584-12588.
2. Cesura AM, Ritter A, Picotti GB and Da Prada M (1987) Uptake, release, and subcellular localization of 1-methyl-4-phenylpyridinium in blood platelets. J Neurochem 49:138-145.
3. 1 by calcitonin. Proc Natl Acad Sci USA 91:2115-2119.
4. Erecinska M, Nelson D, Dagani F, Deas J and Silver IA (1993) Relations between intracellular ions and energy metabolism under acidotic conditions: A study with nigericin in synaptosomes, neurons, and C6 glioma cells. J Neurochem 61:1356-1368.
5. Eshleman AJ, Stewart E, Evenson AK, Mason JN, Blakely RD, Janowsky A and Neve KA (1997) Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters. J Neurochem 69:1459-1466.
6. Evinger MJ, Ernsberger P, Regunathan S and Reis DJ (1995) Regulation of phenylethanolamine N-methyltransferase gene expression by imidazoline receptors in adrenal chromaffin cells. J Neurochem 65:988-997.
7. Gu H, Wall SC and Rudnick G (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 269:7124-7130.
8. Guldberg HC and Marsden CA (1975) Catechol-O-methyl transferase: Pharmacological aspects and physiological role. Pharmacol Rev 27:135-206.
9. 1: Inhibition by amiloride and its derivatives. Biochem Biophys Res Commun 127:759-767.
10. Hatta E, Maruyama R, Marshall SJ, Imamura M and Levi R (1999) Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts. J Pharmacol Exp Ther 288:919-927.
11. 3 receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia. J Pharmacol Exp Ther 283:494-500.
12. 2-adrenoceptors. Circ Res 78:475-481.
13. Iversen LL and Kravitz EA (1966) Sodium dependence of transmitter uptake at adrenergic nerve terminals. Mol Pharmacol 2:360-362.
14. Kleyman TR and Cragoe EJJ (1988) Amiloride and its analogs as tools in the study of ion transport. J Membr Biol 105:1-21.
15. Kubler W and Strasser RH (1994) Signal transduction in myocardial ischaemia. Eur Heart J 15:437-445. Editorial.
16. Kurz T, Richardt G, Seyfarth M and Schömig A (1996) Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue. Naunyn Schmiedeberg's Arch Pharmacol 354:7-16.
17. Pacholczyk T, Blakely RD and Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature (Lond) 350: 350-354.
18. Paton DM (1973) Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria. Br J Pharmacol 49:614-627.
19. - of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters. Br J Pharmacol 121:205-212.
20. Pifl C, Hornykiewicz O, Giros B and Caron MG (1996) Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: Studies comparing the cloned human noradrenaline and human dopamine transporter. J Pharmacol Exp Ther 277:1437-1443.
21. Regunathan S, Youngson C, Wang H and Reis DJ (1995) Imidazoline receptors in vascular smooth muscle and endothelial cells. Ann NY Acad Sci 763:580-590.
22. 3H]GABA release. Neurochem Res 21:889-895.
23. + in neuronal uptake: Kinetic evidence for CO-transport. Naunyn Schmiedeberg's Arch Pharmacol 309:99-107.
24. Scherman D and Henry JP (1984) Reserpine binding to bovine chromaffin granule membranes: Characterization and comparison with dihydrotetrabenazine binding. Mol Pharmacol 25:113-122.
25. + exchange in proximal tubule cells and cortical collecting duct. Kidney Int 52:454-459.
26. Schömig A, Haass M and Richardt G (1991) Catecholamine release and arrhythmias in acute myocardial ischaemia. Eur Heart J 12 (Suppl F):38-47.
27. Schomig E, Michael-Hepp J and Schonfeld CL (1989) Inhibition of neuronal noradrenaline transport (uptake1) and desipramine binding by amiloride and ethylisopropylamiloride. Naunyn Schmiedeberg's Arch Pharmacol 340:495-501.
28. Stute N and Trendelenburg U (1984) The outward transport of axoplasmic noradrenaline induced by a rise of the sodium concentration in the adrenergic nerve endings of the rat vas deferens. Naunyn Schmiedeberg's Arch Pharmacol 327:124-132.
29. Trendelenburg U (1991) The TiPS lecture: Functional aspects of the neuronal uptake of noradrenaline. Trends Pharmacol Sci 12:334-337.
30. Wall SC, Gu H and Rudnick G (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: Amphetamine specificity for inhibition and efflux. Mol Pharmacol 47:544-550.